Final answer:
The FDA has not approved any drugs specifically for preventing bloodborne virus infections following an occupational exposure, but there are approved drugs and treatments that can be used in post-exposure situations.
Step-by-step explanation:
The FDA has not approved any drugs specifically for preventing bloodborne virus infections following an occupational exposure. However, there are certain approved drugs and treatments that can be used in post-exposure situations. For example, in the case of hepatitis B (HBV) infection, health-care workers may receive post-exposure treatment with hepatitis B immunoglobulin (HBIG) and vaccination.